Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PROTEIN DESIGN LABS INC/DE | 75,826 | reported | 19 Aug 2020 | tx 3+194,497 |
| XOMA Royalty Corp | 12,592 | reported | 21 May 2026 | tx 9+59,788 |
| Janux Therapeutics, Inc. | 8,731 | reported | 11 Jun 2025 | tx 8+53,309 |
| Nivalis Therapeutics, Inc. | 0 | reported | 20 May 2024 | tx 10+60,150−60,150 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | XOMA Royalty Corp | 3,586 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 3,750 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 11,667 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | XOMA Royalty Corp | 5,971 | 0.00 USD | |
| 19 Jul 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 5,000 | 0.00 USD | |
| 19 Jul 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 2,500 | 0.00 USD | |
| 19 Jul 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 8,350 | 0.00 USD | deriv |
| 19 Jul 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 16,700 | 0.00 USD | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 15,000 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 7,650 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 17,500 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 10,000 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 10,000 | — | deriv |
| 15 May 2024 | GRANT_AWARD | XOMA Royalty Corp | 3,035 | 0.00 USD | |
| 15 May 2024 | GRANT_AWARD | XOMA Royalty Corp | 4,881 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
| 17 May 2023 | GRANT_AWARD | XOMA Royalty Corp | 10,967 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 18 May 2022 | GRANT_AWARD | XOMA Royalty Corp | 8,996 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 19 May 2021 | GRANT_AWARD | XOMA Royalty Corp | 5,101 | 0.00 USD | deriv |
| 04 Jan 2021 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 7,650 | 0.00 USD | deriv |
| 15 Dec 2020 | GRANT_AWARD | XOMA Royalty Corp | 4,000 | 25.00 USD | |
| 10 Dec 2020 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 19 Aug 2020 | GRANT_AWARD | PROTEIN DESIGN LABS INC/DE | 25,826 | 0.00 USD |